Shopping Cart
Remove All
Your shopping cart is currently empty
Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Cas No. | 1821402-21-4 |
| Storage | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.